ConductScience.org, home

Trial · NCT05208333

The Effectiveness of Albendazole Treatment Among Infected Toxocara Children

NCT05208333, Not applicable, Unknown, Pham Ngoc Thach University of Medicine

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. The Effectiveness of Albendazole Treatment Among Infected Toxocara Children. Trials, record NCT05208333. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT05208333

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
The Effectiveness of Albendazole Treatment Among Infected Toxocara Children
NCT number
NCT05208333
Status
Unknown
Phases
Not applicable
Enrollment
960 participants, estimated
Lead sponsor
Pham Ngoc Thach University of Medicine
Conditions
Toxocara Infection
Interventions
Albenza 200Mg Tablet
First posted
2022-01-26
Last updated
2022-04-20

Source ClinicalTrials.gov

Registered outcomes4

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryProcedures Guidelines for diagnosis, treatment, and post-treatment follow-up of Toxocariasis larvae12 months
After phase 1, we hope that we can draw a new procedure guideline for the diagnosis and treatment. And after this study is done, the new standard of guidelines for treatment of Toxocariasis infection can be applied for all children hospital in Vietnam.
SecondarySeminars on treatment and follow-up after treatment of toxocariasis12 months
After the phase 1 of the study, we can oganize the seminars based on the knowledge we have reviewed and will discuss about the treatment and follow-up to all the medical doctors who are interested in this topic.
SecondaryPet care consultation club, how to prevent toxocariasis12 months
This club will invite the parents and anyone who care about taking care of animals such as dogs, cats at the family participate in this consultation club to provide information related to Toxocariasis infection and will educate them how to prevent infecting from Toxocariasis for children at home.
SecondaryPublishing journal articles24 months
Based on the reviewing the epidemiology and the situation about Toxocariasis in Vietnam, we can publish an article on it. After the phase 1 is done, we can publish the second article and after the phase 2 is done, we can publish the third one.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers1

The papers the trial lists on ClinicalTrials.gov.

PMIDListed as
39253804DERIVED

Source PubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT05208333

GET https://conductscience.org/api/trials/v1/NCT05208333/registered